111 related articles for article (PubMed ID: 18487909)
41. Clinical benefit of intermittent administration of imatinib in a patient with metastatic gastrointestinal stromal tumour.
Morabito A; Longo R; Carillio G; Bonginelli P; Vitale S; Gasparini G
Clin Oncol (R Coll Radiol); 2005 Apr; 17(2):96-7. PubMed ID: 15830571
[TBL] [Abstract][Full Text] [Related]
42. Optimal duration of adjuvant therapy for patients with resected gastrointestinal stromal tumors.
Blanke CD
JAMA; 2012 Mar; 307(12):1312-4. PubMed ID: 22453573
[No Abstract] [Full Text] [Related]
43. Avapritinib (Ayvakit) for GIST.
Med Lett Drugs Ther; 2021 Feb; 63(1617):23-24. PubMed ID: 33647006
[No Abstract] [Full Text] [Related]
44. Imatimid-induced bone marrow necrosis detected on MRI examination and mimicking bone metastases.
Vanel D; Bonvalot S; Pechoux CL; Cioffi A; Domont J; Cesne AL
Skeletal Radiol; 2007 Sep; 36(9):895-8. PubMed ID: 17589841
[TBL] [Abstract][Full Text] [Related]
45. Gastrointestinal cancer: Management of GIST--go beyond imatinib: treat resistant subtypes.
Pantaleo MA; Biasco G
Nat Rev Clin Oncol; 2015 Aug; 12(8):440-2. PubMed ID: 26077043
[No Abstract] [Full Text] [Related]
46. Nilotinib, imatinib, and GIST therapy.
Garcia del Muro X
Lancet Oncol; 2015 May; 16(5):483-4. PubMed ID: 25882983
[No Abstract] [Full Text] [Related]
47. Nilotinib versus imatinib for GIST.
Gougis P; Paci A; Coriat R; Urien S; Mir O
Lancet Oncol; 2015 Jul; 16(7):e311. PubMed ID: 26149879
[No Abstract] [Full Text] [Related]
48. Discovery of N-(3-((1-Isonicotinoylpiperidin-4-yl)oxy)-4-methylphenyl)-3-(trifluoromethyl)benzamide (CHMFL-KIT-110) as a Selective, Potent, and Orally Available Type II c-KIT Kinase Inhibitor for Gastrointestinal Stromal Tumors (GISTs).
Wang Q; Liu F; Wang B; Zou F; Chen C; Liu X; Wang A; Qi S; Wang W; Qi Z; Zhao Z; Hu Z; Wang W; Wang L; Zhang S; Wang Y; Liu J; Liu Q
J Med Chem; 2016 Apr; 59(8):3964-79. PubMed ID: 27077705
[TBL] [Abstract][Full Text] [Related]
49. Nilotinib versus imatinib for GIST - Authors' reply.
Blay JY; Hurh E; Green S; Novick S
Lancet Oncol; 2015 Jul; 16(7):e311-2. PubMed ID: 26149878
[No Abstract] [Full Text] [Related]
50. Quantification of the anti-leukemia drug STI571 (Gleevec) and its metabolite (CGP 74588) in monkey plasma using a semi-automated solid phase extraction procedure and liquid chromatography-tandem mass spectrometry.
Bakhtiar R; Khemani L; Hayes M; Bedman T; Tse F
J Pharm Biomed Anal; 2002 Jun; 28(6):1183-94. PubMed ID: 12049982
[TBL] [Abstract][Full Text] [Related]
51. [Targeted therapy combined with immunotherapy in gastrointestinal stromal tumor: a new era of hope and challenges].
Zhao W; Cao H
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):966-971. PubMed ID: 28900984
[TBL] [Abstract][Full Text] [Related]
52. Targeted drug therapies and cancer.
Yim KL; Cunningham D
Recent Results Cancer Res; 2011; 185():159-71. PubMed ID: 21822826
[TBL] [Abstract][Full Text] [Related]
53. [Gastrointestinal gastric tumor (GIST) as a cause of massive hemorrhage from the upper digestive tract].
Djukić V; Karamarković A; Mijatović S; Micev M; Bumbasirević V; Djurović M; Stepić D; Jeremić V; Popović N; Sijacki A; Krsić S; Gregorić P
Acta Chir Iugosl; 2007; 54(1):169-71. PubMed ID: 17633880
[TBL] [Abstract][Full Text] [Related]
54. Changes and challenges--the world post-Gleevec (Glivec).
Hickman JA; Lazo JS
Curr Opin Pharmacol; 2002 Aug; 2(4):357-60. PubMed ID: 12127866
[No Abstract] [Full Text] [Related]
55. Recent advances and novel agents for gastrointestinal stromal tumor (GIST).
Lamba G; Ambrale S; Lee B; Gupta R; Rafiyath SM; Liu D
J Hematol Oncol; 2012 May; 5():21. PubMed ID: 22569033
[TBL] [Abstract][Full Text] [Related]
56. Methodological aspects of current problems in target-based anticancer drug development.
Yamanaka T; Okamoto T; Ichinose Y; Oda S; Maehara Y
Int J Clin Oncol; 2006 Jun; 11(3):167-75. PubMed ID: 16850122
[TBL] [Abstract][Full Text] [Related]
57. What is New in Gastrointestinal Stromal Tumor?
Schaefer IM; Mariño-Enríquez A; Fletcher JA
Adv Anat Pathol; 2017 Sep; 24(5):259-267. PubMed ID: 28632504
[TBL] [Abstract][Full Text] [Related]
58. "Wild type" GIST: Clinicopathological features and clinical practice.
Wada R; Arai H; Kure S; Peng WX; Naito Z
Pathol Int; 2016 Aug; 66(8):431-7. PubMed ID: 27427238
[TBL] [Abstract][Full Text] [Related]
59. Rare gastrointestinal stromal tumors (GIST): omentum and retroperitoneum.
Sawaki A
Transl Gastroenterol Hepatol; 2017; 2():116. PubMed ID: 29354773
[TBL] [Abstract][Full Text] [Related]
60. Imaging pediatric gastrointestinal stromal tumor (GIST).
Herzberg M; Beer M; Anupindi S; Vollert K; Kröncke T
J Pediatr Surg; 2018 Sep; 53(9):1862-1870. PubMed ID: 29685489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
